Global molecular diagnostics company Genetic Signatures (ASX: GSS) has decided to halt the development of its EasyScreen Essentials Respiratory Detection…
Flu season is around the corner, typically affecting us between May and September. Just in time for that, Australian global…
Gastrointestinal (GI) parasites are a pressing public health issue, affecting both humans and animals. Unfortunately, these diseases often go undiagnosed…
Every day there are more than 1 million sexually transmitted infections (STI) contracted, but biotech company Genetic Signatures (ASX: GSS)…
Normally investors shun speculative plays in times of market uncertainties, but that’s not been the case with ASX-listed life sciences…
Biotech company Genetic Signatures (ASX: GSS) is poised to play a major role in flattening the curve of coronavirus cases…